ArticleAmerican journal of cancer research2024

Predicting immunotherapy-related adverse events in late-stage non-small cell lung cancer with KARS G12C mutation treated with PD-1 inhibitors through combined assessment of LCP1 and ADPGK expression levels.

Lei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.